Matches 1 - 50 out of 313 1 2 3 4 5 6 7 >


Match Document Document Title
US20140134213 TREATMENT OF MICROBIAL INFECTIONS  
The present application relates to an anti-microbial system for use in the treatment of microbial infections or control of microbial contamination, which avoids the use of antibiotics. Such...
US20100330013 AMADORIASES IN WASHING AND CLEANING PRODUCTS  
Body care products, hair care products, shampoos, oral care, dental care and dental prosthesis care products, dental brace care products, cosmetics, therapeutics, washing agents, cleaning agents,...
US20140314732 CROSS-LINKED COMPOSITIONS  
Improved compositions comprising a cross-linkable protein or polypeptide, and a non-toxic material which induces cross-linking of the cross-linkable protein. The compositions are optionally and...
US20130336946 FUSION PROTEINS AND METHODS FOR TREATING HIV INFECTION AND AIDS RELATED SYMPTOMS  
The present invention discloses pharmaceutical compositions and methods for using a fusion protein comprising a superoxide dismutase and a transit peptide. The present invention also discloses...
US20140348881 METHOD FOR DIAGNOSING AND TREATING DYSAUTONOMIA AND OTHER DYSAUTONOMIC CONDITIONS  
A method for treating a Parkinson's patient with digestive/pancreatic enzymes involves administering an effective amount of digestive/pancreatic enzymes to an individual having the disorder in...
US20140328818 Proteases for Degrading Gluten  
Gluten-degrading proteases derived from insects, including flour beetles, are isolated, and the purified, and recombinant forms can be used to make gluten-containing food safe for patients...
US20120207732 COMPOSITIONS AND METHODS FOR PROMOTING NEURONAL OUTGROWTH  
Neural outgrowth in the central nervous system is achieved by administering chondroitinase AC and/or chondroitinase B to degrade chondroitin sulfate proteoglycans that inhibit or contribute to the...
US20140140975 TREATMENTS INVOLVING GLUTAREDOXINS AND SIMILAR AGENTS  
The present invention generally relates to treatments involving glutaredoxins. In one aspect, systems and methods of the invention can be used to treat a subject having an oxidative stress...
US20130202564 Systems and Methods of Cell Activated, Controlled Release Delivery of Growth Factors for Tissue Repair and Regeneration  
This invention provides a composition for controlled-release of polypeptide growth factors useful in tissue repair or engineering. The composition include a polypeptide growth factor covalently...
US20130224172 METHODS OF TREATING BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS  
Disclosed herein are methods of using coated digestive enzyme preparations and enzyme delivery systems and pharmaceutical compositions comprising the preparations for treatment of subjects having...
US20140154229 PROTEOLYTIC EXTRACT FROM BROMELAIN FOR THE TREATMENT OF CONNECTIVE TISSUE DISORDERS  
The present invention relates to a proteolytic extract obtained from bromelain for the treatment of connective tissue diseases. In particular, the present invention relates to a pharmaceutical...
US20140127180 MUTANT CYTOCHROME P450 2B6 PROTEINS AND USES THEREOF  
The present invention to relates mutant human cytochrome P450 2B6 (CYP2B6) proteins, and fusion proteins comprising said mutant CYP2B6 proteins. In particular, fusion proteins comprising mutant...
US20110142756 Method And Composition For The Treatment Of Cancer By The Enzymatic Conversion Of Soluble Radioactive Toxic Precipitates In The Cancer  
The invention features compositions and methods for treating or alleviating a symptom of cancer. The compositions and methods of the invention direct supra-lethal doses of radiation, called...
US20150023944 Method of Treating and Diagnosing Parkinson's Disease and Related Dysautonomic Disorders  
A method for treating a Parkinson's patient with digestive/pancreatic enzymes involves administering an effective amount of digestive/pancreatic enzymes to an individual having the disorder in...
US20130195887 PHARMACOLOGICAL VITREOLYSIS  
A method of treating or preventing a disorder, or a complication of a disorder, of an eye of a subject comprising contacting a vitreous and/or aqueous humor with a composition comprising a...
US20110064712 Dietary Supplement Compositions and Methods of Making and Using the Same  
Dietary supplement compositions are disclosed. Methods of making and using dietary supplement compositions are also disclosed.
US20120134925 Application and Uses of PRG4 and Therapeutic Modulation Thereof  
The present invention relates to the uses of the protein PRG4 and therapeutic modulation thereof. In particular, the present invention relates compositions and methods utilizing PRG4 and...
US20130142770 BOTULINUM TOXIN COMPOSITIONS AND METHODS  
Disclosed herein are methods of using extracellular matrix digesting enzymes and neurotoxins, such as a Clostridial neurotoxins, to treat various medical conditions, such as overactive bladder,...
US20130129699 BOTULINUM TOXIN COMPOSITIONS AND METHODS  
Disclosed herein are methods of using extracellular matrix digesting enzymes and neurotoxins, such as a Clostridial neurotoxins, to treat various medical conditions, such as overactive bladder,...
US20120177624 ORAL DISINFECTANT, AND FOOD ADDITIVE COMPRISING THE DISINFECTANT  
Disclosed is a disinfectant which is safe, has few adverse side-effects, can be ingested together with a food or beverage by adding the disinfectant to the food or beverage, shows a bactericidal...
US20110300109 COMPOSITIONS AND METHODS FOR TREATING CANCER  
The present invention is based, in part, on our discovery of compositions and methods that can be used to systemically deplete arginine and thereby treat arginine-dependent cancers. Our studies...
US20150104489 THERAPEUTIC FOR TREATING CLOSTRIDIUM DIFFICILE INFECTION  
The invention relates to deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a pharmaceutical or veterinary composition or formulation comprising at least...
US20140212492 Oral Enzyme Compositions for Intestinal Delivery  
The present disclosure describes compositions for intestinal delivery of enzyme formulations and methods of treating health problems with these formulations. More specifically, the enzyme...
US20130236439 ENZYME-ACTIVATED COLLAGEN AND TISSUE MATRICES  
Devices and methods for treating defects in connective tissue are provided along with methods for making such devices. The devices can include enzyme-activated acellular tissue matrices that...
US20130084320 TISSUE FUSION METHOD USING COLLAGENASE FOR REPAIR OF SOFT TISSUE  
The present invention provides a method of using locally administered collagenase as a non-invasive means of enhancing cell release from the cartilage or fibrocartilage tissues adjacent to a...
US20130034529 NATURAL COMPOSITIONS AND METHODS OF PROMOTING WOUND HEALING  
Compositions comprising honey, myrhh, and Nigella Sativa seeds are described. The honey:myrrh:N. sativa seed ratio can be 100:0.5-50:0.1-10, based on weight. The compositions can also comprise one...
US20120308541 PHARMACEUTICAL COMPOSITION FOR TREATING THE GASTROINTESTINAL TRACT  
Provided are pharmaceutical compositions for the treatment or prophylaxis of the gastrointestinal tract. One of the pharmaceutical composition includes co-particles of an adsorbent, and one or...
US20150079062 METHOD FOR HARVESTING, PROCESSING, AND STORAGE OF PROTEINS FROM THE MAMMALIAN FETO-PLACENTAL UNIT AND USE OF SUCH PROTEINS IN COMPOSITIONS AND MEDICAL TREATMENT  
The invention provides a method of harvesting, processing and storing a plurality of proteins from a mammalian feto-placental unit. The method includes dissecting a mammalian uterus to harvest at...
US20150079061 METHOD FOR THE HARVESTING, PROCESSING, AND STORAGE OF PROTEINS FROM THE MAMMALIAN FETO-PLACENTAL UNIT AND USE OF SUCH PROTEINS IN COMPOSITIONS AND MEDICAL TREATMENT  
The invention provides a method of harvesting, processing and storing a plurality of proteins from a mammalian feto-placental unit. The method includes dissecting a mammalian uterus to harvest at...
US20080226568 Synergistic preservative systems and their use in topical compositions  
A synergistic preservative system having an oil-miscible glycol and an enzymatic composition. The synergistic preservative system demonstrates enhanced anti-fungal, anti-bacterial, and...
US20130095152 METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME  
A therapeutic composition for the treatment of the symptoms of complex regional pain syndrome and a method for preparing the therapeutic composition is disclosed. The therapeutic composition is a...
US20130202696 Agent for use in the case of fructose intolerance  
There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose...
US20130202695 Agent for use in the case of fructose intolerance  
There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose...
US20120258149 Methods and Compositions for the Prevention and Treatment of Influenza  
This disclosure relates to the prevention and treatment of Influenza, and more particularly Influenza A Virus Subtype H1N1, with the use of a pharmaceutical composition comprising one or more...
US20140186436 ORAL DELIVERY OF ENZYMES BY NANOCAPSULES FOR TARGETED METABOLISM OF ALCOHOL OR TOXIC METABOLITES  
The invention disclosed herein includes nanocomplexes that are designed include enzymes that have complementary functional attributes and methods for using these nanocomplexes. Illustrative...
US20100322912 Combination Enzyme Therapy for Gastric Digestion of Dietary Gluten in Celiac Sprue Patients  
Combination enzyme products and methods of use thereof are provided. Aspergillopepsin I is combined with a protease enzyme that provides for an additive or synergistic effect in the digestion of...
US20130302411 Agent for use in the case of fructose intolerance  
There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose...
US20130202694 Agent for use in the case of fructose intolerance  
There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose...
US20140248251 Methods and Pharmaceutical Compositions for Treating Celiac Disease and Gluten Intolerance  
The invention concerns methods for protecting a subject in need from a deleterious effect of gluten ingestion. The invention specifically concerns the treatment of celiac disease and gluten...
US20140105880 USE OF P97 AS AN ENZYME DELIVERY SYSTEM FOR THE DELIVERY OF THERAPEUTIC LYSOSOMAL ENZYMES  
The present invention provides for compositions and methods for treating, ameliorating or preventing a lysosomal storage disease by administering to a patient suffering from a lysosomal storage...
US20110091436 USE OF MATRIX METALLOPROTEINASE-10 (MMP-10) FOR THROMBOLYTIC TREATMENTS  
The present invention relates to the use of matrix metalloproteinase MMP-10 in the preparation of a pharmaceutical composition useful for thrombolytic therapy, it also being possible for said...
US20130259848 ENZYME COMBINATIONS TO REDUCE BRAIN TISSUE SWELLING  
Tissue fixed charge density (FCD) is identified as another potential therapeutic target for reducing brain tissue swelling. Reduction of the FCD could reduce the thermodynamic force driving water...
US20150093369 MIXTURE OF ENZYMES FROM ANTARCTIC KRILL FOR USE IN THE REMOVAL OF A BIOFILM  
The invention concerns a mixture of enzymes from krill for use in the treatment of a soft tissue including epithelial tissue and mucosa on which soft tissue a biofilm has formed or is expected to...
US20130224171 AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE  
5-D-fructose dehydrogenase, optionally in combination with invertase and/or maltase and/or glucose isomerase, may be used to treat fructose intolerance. Other embodiments are also disclosed.
US20130034530 Dietary Supplement Cognitive Support System  
The present invention relates to a nutritional supplement composition, comprising a therapeutically effective amounts of Vitamin C, Vitamin D3, Thiamin, Riboflavin, Niacin, Vitamin B6, Folic acid,...
US20140134146 POLYSILOXANE-BASED FOULING RELEASE COATS INCLUDING ENZYMES  
The present application discloses a fouling release cured paint coat comprising a polysiloxane-based binder matrix constituting at least 40% by dry weight of the coat, and one or more enzymes. The...
US20150216952 TREATMENT OF OPHTHALMIC CONDITIONS  
Ophthalmic conditions such as presbyopia, myopia, and astigmatism can be corrected by the use of a molding contact lens in combination with a pharmaceutical composition suitable for delivery to...
US20140271597 TREATMENT OF OPHTHALMIC CONDITIONS  
Ophthalmic conditions such as presbyopia, myopia, and astigmatism can be corrected by the use of a molding contact lens in combination with a pharmaceutical composition suitable for delivery to...
US20140017220 TREATMENT OF OPHTHALMIC CONDITIONS  
Ophthalmic conditions such as presbyopia, myopia, and astigmatism can be corrected by the use of a molding contact lens in combination with a pharmaceutical composition suitable for delivery to...
US20050244396 Application of a non-toxic organic enzyme formulation and process for reducing fungi-caused decay on fruits and vegetables  
An enzyme formulation is provided for preventing fungi and their proteins from forming on fruits and vegetables, and for extending the shelf life of the fruits and vegetables from field...

Matches 1 - 50 out of 313 1 2 3 4 5 6 7 >